Dupixent ® (dupilumab) Approved in the U.S. as the Only Targeted Medicine to Treat Patients with Bullous Pemphigoid (BP)

The signals of workplace submissiveness

Author9 minutes ago 0

Apollo to finance UK Hinkley Point nuclear plant with £4.5bn loan

Author11 minutes ago 0

Why elite MBA graduates are struggling to find jobs

Author22 minutes ago 0

FC Barcelona Dream Still Chased By Premier League Ace Despite Williams

Author35 minutes ago 0